ArtiQ, a spin-off from the Belgian university KU Leuven, is a leading innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions. Moreover, ArtiQ strives to streamline and optimize respiratory clinical trials for pharmaceutical companies. Through the development and provision of cutting-edge AI-first software, ArtiQ empowers traditional respiratory devices and processes.
In April 2024, ArtiQ joined forces with Clario, a leading healthcare research and technology company. This collaboration allows ArtiQ to broaden its reach globally across various clinical trials and sponsors, aiming to extend its impact beyond respiratory care and foster positive outcomes in healthcare worldwide.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Leuven, Flemish Region 3000, Be
- in****@****rtiq.eu
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- artiq.eu
- Keywords
- Pulmonary function tests, Respiratory problems, Lung diseases, Artificial Intelligence, Digital Health, Diagnostics, Decision support systems.
- HQ
- Leuven, Flemish Region
Artiq Questions
Artiq's website is artiq.eu
Artiq's LinkedIn profile is https://be.linkedin.com/company/artiq-eu
Artiq has
21 employees.
View email and phone details for 21
employees at Artiq.
Artiq's industry is
Hospitals and Health Care
Artiq's top competitors are
Icometrix,
Urbantz,
Relu,
Predikt,
Nobi Smart Lights,
Aividens,
Clario,
Yields,
Stellar Labs,
Enersee.
Artiq's support email address is info@artiq.eu
Artiq's categories are Hospitals and Health Care
Artiq's founding year is 2019
